Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Long Term Follow-up Data after Consolidation Therapy with Ponatinib in Combination with Cytarabine in Patients with FLT3 Mutated Acute Myeloid Leukemia in First Complete Remission

Blood (2024) 144 (Supplement 1): 2905.

https://doi.org/10.1182/blood-2024-209998

Published: 2024

Journal Articles

Impact of Residence in an Agricultural Zone on AML Characteristics

Vincent Marmouset, Berengere Gruson, Veronique Harrivel, Céline Berthon, Nicolas Duployez, Claude Preudhomme, Jean Pierre Marolleau, Pierre Morel, Carine Hauspie, Stéphane Morisset, Delphine Lebon

Blood (2023) 142 (Supplement 1): 2842.

https://doi.org/10.1182/blood-2023-173171

Published: 2023

Journal Articles

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Blood (2023) 142 (Supplement 1): 1516.

https://doi.org/10.1182/blood-2023-173379

Published: 2023

Journal Articles

Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-137469

Published: 2020

Journal Articles

Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment

Dujardin Adèle, Pierre Morel, MD, Alexis Caulier, MD, Magalie Joris, MD, Amandine Charbonnier, MD, Berengere Gruson, MD, Marine Quint, Marie-Noëlle Lacassagne, Sandrine Castelain, MD PhD, Jean-Pierre Marolleau, MD PhD, Delphine Lebon, MD

Blood (2019) 134 (Supplement_1): 2007.

https://doi.org/10.1182/blood-2019-123283

Published: 2019

Journal Articles

Immunomodulation with Azacytidine and Donor Lymphocyte Infusion Following Sequential Conditioning Allogenic Stem Cell Transplantation Improves Outcome of Unfavorable AML

Magalie Joris, Delphine Lebon, MD, Amandine Charbonnier, MD, Pierre Morel, MD, Berengere Gruson, MD, Alexis Caulier, MD, Caroline Delette, MD, Marie-Noëlle Lacassagne, Nicolas Guillaume, Loïc Garçon, Jean-Pierre Marolleau, MD PhD

Blood (2019) 134 (Supplement_1): 4600.

https://doi.org/10.1182/blood-2019-131314

Published: 2019

Journal Articles

Chemotherapy Treatment Doesn't Beneficiate to a Group of Elderly AML Patients with Absence of Complex Karyotype and Circulating Blasts

Berengere Gruson, MD, Magalie Joris, Olivier Nibourel, Véronique Harrivel, MD, Nathalie Cambier, MD, Pauline Lionne, Bachra Choufi, Celine Rodriguez, Cecile Frimat, Isabelle Plantier, MD, Laure Stalnikiewicz, Maxime Bemba, Céline Berthon, MD PhD, Claude Preudhomme, Pierre Morel, MD, Jean-Pierre Marolleau, MD PhD

Blood (2018) 132 (Supplement 1): 2679.

https://doi.org/10.1182/blood-2018-99-116144

Published: 2018

Journal Articles

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Blood (2018) 132 (Supplement 1): 467.

https://doi.org/10.1182/blood-2018-99-111756

Published: 2018

Journal Articles

A Phase II Trial of Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Thrombocytopenia

Raphael Itzykson, MD PhD, Jérôme Lambert, MDPhD, Daniela Barbieri, Berengere Gruson, Sylvain Thepot, MD, Thorsten Braun, MD PhD, Norbert Vey, Jacques Delaunay, MD, Laurence Legros, MD PhD, Julie Lejeune, Rosa Sapena, Nathalie Droin, Francoise Porteu, Eric Solary, MD, Pierre Fenaux, MD PhD

Blood (2017) 130 (Supplement 1): 4266.

https://doi.org/10.1182/blood.V130.Suppl_1.4266.4266

Published: 2017

Journal Articles

Body Mass Index at 3 Weeks after Intensive Induction Regimen Is a Prognostic Factor for the Risk of Relapse and/or Failure in Patients with Acute Myeloid Leukemia

Lea Loriguet, Momar Diouf, Berengere Gruson, MD, Delphine Lebon, MD, Amandine Charbonnier, MD, Dorothée Laine, Pierre Morel, MD, Jean Pierre Marolleau, MD PhD

Blood (2016) 128 (22): 5972.

https://doi.org/10.1182/blood.V128.22.5972.5972

Published: 2016

Journal Articles

Sequential Allogeneic Transplantation for Multiple Myeloma Patient in Early Relapse Post-Autograft

Amandine Charbonnier, MD, Berengere Gruson, MD, Delphine Lebon, MD, Marie Beaumont, MD, Lavinia Merlusca, MD, Pierre Morel, MD, Jean-Pierre Marolleau, MD PhD, Bruno Royer, MD

Blood (2016) 128 (22): 5768.

https://doi.org/10.1182/blood.V128.22.5768.5768

Published: 2016

Journal Articles

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Eve Poret, Chrystelle Vidal, Yohan Desbrosses, Fanny Angelot Delettre, Maider Pagadoy, Aurore Pugin, Louis Benazet, Franck Leroux, Elise Robert, Delphine Binda, Sabeha Biichle, Anne Roggy, PhDSTUDENT, Laure Philippe, MDcal student, Berengere Gruson, Anne-Claire Gac, Michel Maigre, Denis Caillot, Remy Gressin, MD, Pascal Turlure, MD, Anne-Sophie Michallet, MD, Lila Gilis, Veronique Dorvaux, Yazid Arkam, Caroline Bonmati, MD, Pierre Péterlin, Pierre-Simon Rohrlich, MD PhD, Thorsten Braun, MD PhD, jean-Valere Malfuson, Didier Bouscary, MDPhD, Eric Pujade-Lauraine, Felipe Suarez, MD PhD, Carole Soussain, MD, Etienne Lengliné, MD, Mathieu Puyade, MD, Tony Marchand, MD, Denis Guyotat, Bruno Lioure, MD, Christian Recher, MD, Damien Roos-Weil, Fabrice Jardin, Jean-Pierre Marolleau, Bernard Drenou, MD, Bernard Bonnotte, MD PhD, Sophie Dalac, Philippe Saas, PhD, Francine Garnache Ottou, PhD, Eric Deconinck

Blood (2015) 126 (23): 456.

https://doi.org/10.1182/blood.V126.23.456.456

Published: 2015

Journal Articles

Rural but Not Urban AML Exhibit Cytogenetic and Molecular Characteristics of Therapy-Related AML

Berengere Gruson, MD, Sarah Ivanoff, Céline Berthon, MD PhD, Veronique Harrivel, MD, Olivier Nibourel, PhD, Cécile Frimat, Claude Preudhomme, MD PhD, Jean-Pierre Marolleau, MD PhD

Blood (2014) 124 (21): 2353.

https://doi.org/10.1182/blood.V124.21.2353.2353

Published: 2014

Journal Articles

AML At First Relapse: A Real Life Picture

Eileen Mary Boyle, MD, Claude Preudhomme, MD, PhD, Olivier Nibourel, Catherine Roche-Lestienne, PhD, Gareth J Morgan, MD PhD, Brigitte Dupriez, MD, Isabelle Plantier, MD, Berengere Gruson, MD, Jean Pierre Marolleau, MD, PhD, Delphine Lebon, MD, Jose Fernandes, MD, Christophe Willekens, Bruno Quesnel, MD, PhD, Céline Berthon, MD, PhD

Blood (2013) 122 (21): 3895.

https://doi.org/10.1182/blood.V122.21.3895.3895

Published: 2013

Journal Articles

Outcome and treatment of 62 Patients Aged Over 75 Years with Low Grade Non Hodgkin Lymphoma

Anne Parcelier, Isabelle Leduc, Lavinia Merlusca, Gandhi Damaj, Amandine Charbonnier, Berengere Gruson, Saliha Sid-Idris, Jean Pierre Marolleau, MD, PhD, Bruno Royer

Blood (2012) 120 (21): 4854.

https://doi.org/10.1182/blood.V120.21.4854.4854

Published: 2012

Journal Articles

Azacitidine in Relapsed and Refractory AML: Efficacy for Patients Relapsing As MDS Post AML

Sarah Ivanoff, Emilie Lemasle, Berengere Gruson, Lavinia Merlusca, Amandine Charbonnier, Anne Parcelier, Gandhi Damaj, Bruno Royer, Jean Pierre Marolleau, MD

Blood (2012) 120 (21): 4332.

https://doi.org/10.1182/blood.V120.21.4332.4332

Published: 2012

Journal Articles

Thalidomide in Advanced Mastocytosis. Results from an Open-Label, Multicentric, Phase II Study

Berengere Gruson, Olivier Lortholary, MD, PhD, Danielle Canioni, marie-Olivia Chandesris, Fanny Lanternier, Bernard Grosbois, Sr., MD, Cristina Livideanu, MD, Thierry Lamy, MD, PhD, Henri Sevestre, MD, PhD, Claire Larroche, MD, Aurélie Esparcieux, MD, Guillaume Chaby, MD, Jean Pierre Marolleau, MD, Olivier Hermine, MD, PhD, Gandhi Damaj, MD

Blood (2011) 118 (21): 1754.

https://doi.org/10.1182/blood.V118.21.1754.1754

Published: 2011

Journal Articles

Methotrexate-Asparaginase-Dexamethasone Regimen for Blastic Plasmocytoid Dendritic Cell Neoplasm treatment

Ioana Vaida, Bruno Royer, Berengere Gruson, Gandhi Damaj, MD, Veronique Harrivel, Jean Pierre Marolleau, MD

Blood (2010) 116 (21): 2194.

https://doi.org/10.1182/blood.V116.21.2194.2194

Published: 2010

Journal Articles

Methylprednisolone-induced immune thrombocytopenia

Bruno Royer, Ketty Lee, Berengere Gruson, France Roszkiewicz, Abdullatif Al Khedr, Agnes Colson, Agnes Camboulives, Philippe Bierling, Jean Pierre Marolleau

Blood (2010) 115 (26): 5431–5432.

https://doi.org/10.1182/blood-2010-01-264986

Published: 2010

Journal Articles

Bortezomib, Doxorubicin and Dexamethasone (PAD) Prior to High-Dose Melphalan / Autologous Stem Cell Transplantation for Newly Diagnosed Plasma Cell Dycrasias.

Delphine Lebon, Berengere Gruson, Reda Garidi, Jean Luc Dutel, Corinne Thevenot, Bachra Choufi, Kamel Ghomary, Brigitte Kolb, Isabelle Leduc, Ioana Vaida, Gandhi Damaj, Jean Pierre Marolleau, MD, Bruno Royer

Blood (2009) 114 (22): 4960.

https://doi.org/10.1182/blood.V114.22.4960.4960

Published: 2009

NARROW

Long Term Follow-up Data after Consolidation Therapy with Ponatinib in Combination with Cytarabine in Patients with FLT3 Mutated Acute Myeloid Leukemia in First Complete Remission

Impact of Residence in an Agricultural Zone on AML Characteristics

Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)

Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study

Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment

Immunomodulation with Azacytidine and Donor Lymphocyte Infusion Following Sequential Conditioning Allogenic Stem Cell Transplantation Improves Outcome of Unfavorable AML

Chemotherapy Treatment Doesn't Beneficiate to a Group of Elderly AML Patients with Absence of Complex Karyotype and Circulating Blasts

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

A Phase II Trial of Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Thrombocytopenia

Body Mass Index at 3 Weeks after Intensive Induction Regimen Is a Prognostic Factor for the Risk of Relapse and/or Failure in Patients with Acute Myeloid Leukemia

Sequential Allogeneic Transplantation for Multiple Myeloma Patient in Early Relapse Post-Autograft

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Rural but Not Urban AML Exhibit Cytogenetic and Molecular Characteristics of Therapy-Related AML

AML At First Relapse: A Real Life Picture

Outcome and treatment of 62 Patients Aged Over 75 Years with Low Grade Non Hodgkin Lymphoma

Azacitidine in Relapsed and Refractory AML: Efficacy for Patients Relapsing As MDS Post AML

Thalidomide in Advanced Mastocytosis. Results from an Open-Label, Multicentric, Phase II Study

Methotrexate-Asparaginase-Dexamethasone Regimen for Blastic Plasmocytoid Dendritic Cell Neoplasm treatment

Methylprednisolone-induced immune thrombocytopenia

Bortezomib, Doxorubicin and Dexamethasone (PAD) Prior to High-Dose Melphalan / Autologous Stem Cell Transplantation for Newly Diagnosed Plasma Cell Dycrasias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only